ScreenerHero

XSPRAY Xspray Pharma AB (publ)

STO · SE · Healthcare · Biotechnology · xspraypharma.com
11.18SEK+3.71%Mkt Cap: 50.71M $P/E: —

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap50.71M USD
Enterprise Value53.85M USD
Revenue (TTM)235.88K USD
Gross Profit235.88K USD
Net Income (TTM)-16.40M USD
Revenue/Share0.06 SEK
Last Price11.18 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees24
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.90
PEG—
EV/EBITDA-3.88
EV/Revenue228.28
P/S241.51
P/B0.92
EPS (TTM)-3.83
EPS (Forward)-1.59
52W Range
9.0604% of range64.10
52W High64.10 SEK
52W Low9.060 SEK
Profitability
Gross Margin100.00%
Oper. Margin-464.62%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-28.35%
ROA-22.28%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.48M USD
CapEx (TTM)2.79M USD
FCF Margin-4963.16%
FCF Yield-23.09%
Net Debt-3.12M USD
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.25
Current Ratio1.39
Quick Ratio1.19
Book Value/Sh13.64 SEK
Cash/Share3.79 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)60.00 SEK
Upside (mean)+436.7%
Target Range60.00 SEK – 60.00 SEK
# Analysts1
Ownership
Shares Out.47.42M
Float33.91M
Insiders22.74%
Institutions43.94%
Technical
SMA 5011.74 (-4.7%)
SMA 20020.76 (-46.2%)
Beta-0.07
S&P 52W Chg14.58%
Avg Vol (30d)90.38K
Avg Vol (10d)121.91K
Technical Indicators
RSI (14)54.5
MACD-0.0374
MACD Signal-0.4082
MACD Hist.+0.3707
BB Upper11.62 SEK
BB Middle9.910 SEK
BB Lower8.198 SEK
BB Width34.55%
ATR (14)0.8358 SEK
Vol Ratio (20d)0.71x